Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia

Fig. 2

Response rates for selected subgroups. CR was noted in black, and additional patients with partial remission were noted in white. (a) Patients with platelet count ≥60 × 109/L acquired significant higher CR and ORR compared with those with platelet count < 60 × 109/L; (b) Patients with platelet count ≥100 × 109/L acquired significant higher CR but not ORR compared with those with platelet count < 100 × 109/L

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us